UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action

Diabetes, obesity & metabolism, 2016-10, Vol.18 (S2), p.3-16

2016

Volltextzugriff (PDF)

Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes

Diabetes, obesity & metabolism, 2016-10, Vol.18 (S2), p.17-24

2016

Volltextzugriff (PDF)

PO428 COMPARATIVE PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF LY2963016 INSULIN GLARGINE AND EU- AND US-APPROVED VERSIONS OF LANTUS® INSULIN GLARGINE IN HEALTHY SUBJECTS

Diabetes research and clinical practice, 2014-11, Vol.106, p.S264-S265

2014

Volltextzugriff (PDF)

PO427 COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 INSULIN GLARGINE PRODUCTS, LY2963016 AND LANTUS® IN HEALTHY SUBJECTS AT 2 DOSE LEVELS

Diabetes research and clinical practice, 2014-11, Vol.106, p.S264-S264

2014

Volltextzugriff (PDF)

Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetes

International journal of clinical pharmacology and therapeutics, 2011-02, Vol.49 (2), p.99-108

2011

Volltextzugriff (PDF)

Exenatide effects on statin pharmacokinetics and lipid response

International journal of clinical pharmacology and therapeutics, 2007-02, Vol.45 (2), p.114-120

2007

Volltextzugriff (PDF)

The effect of exenatide on lisinopril pharmacodynamics and pharmacokinetics in patients with hypertension

International journal of clinical pharmacology and therapeutics, 2009-11, Vol.47 (11), p.651-658

2009

Volltextzugriff (PDF)

Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes

Diabetic medicine, 2006-03, Vol.23 (3), p.240-245

2006

Volltextzugriff (PDF)

A thorough QT study to evaluate the effects of singledose exenatide 10 μg on cardiac repolarization in healthy subjects

International journal of clinical pharmacology and therapeutics, 2011-10, Vol.49 (10), p.594-604

2011

Volltextzugriff (PDF)

Exenatide pharmacokinetics in healthy Chinese subjects

International journal of clinical pharmacology and therapeutics, 2008-09, Vol.46 (9), p.459-465

2008

Volltextzugriff (PDF)

Effect of exenatide on lisinopril pharmacodynamics in patients treated for hypertension

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P14-P14

2005

Volltextzugriff (PDF)

Effect of Exenatide on the Steady-State Pharmacokinetics of Digoxin

Journal of clinical pharmacology, 2005-09, Vol.45 (9), p.1032-1037

2005

Volltextzugriff (PDF)

A single-dose pharmacokinetic study of basal insulin peglispro (BIL) in subjects with hepatic impairment

Diabetologie und Stoffwechsel, 2015, Vol.10 (S 01)

2015

Volltextzugriff (PDF)

The inflammatory and tumor-promoting sesquiterpene lactone, thapsigargin, activates platelets by selective mobilization of calcium as shown by protein phosphorylations

Biochimica et biophysica acta. Molecular cell research, 1987-01, Vol.927 (1), p.65-73

1987

Volltextzugriff (PDF)

PIII-61Exenatide does not affect the pharmacokinetics and pharmacodynamics of warfarin in healthy male subjects

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P75-P75

2006

Volltextzugriff (PDF)

OIV-A-4Chinese are more sensitive to warfarin than Asian Indians despite similar pharmacokinetics and vitamin K levels

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P32-P32

2006

Volltextzugriff (PDF)

PII-39

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P46-P46

2006

Volltextzugriff (PDF)

PII-39Effects of exenatide on statin single-dose pharmacokinetics and 30-week lipid response

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P46-P46

2006

Volltextzugriff (PDF)

OIV-A-4

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P32-P32

2006

Volltextzugriff (PDF)

PIII-61

Clinical pharmacology and therapeutics, 2006-02, Vol.79 (2), p.P75-P75

2006

Volltextzugriff (PDF)

Einfluss von Exenatide auf die Pharmakokinetik einer Statin-Einzeldosis und die Lipidwerte nach 30 Wochen

Diabetologie und Stoffwechsel, 2006, Vol.1 (S 1)

2006

Volltextzugriff (PDF)

Effect of amiloride on arachidonic acid and histamine release from rat mast cells

Agents and Actions, 1989-04, Vol.27 (1-2), p.39-42

1989

Volltextzugriff (PDF)

Inhibition by amiloride and by Na super(+)-depletion of A23187-stimulated arachidonic acid and histamine release from rat mast cells

FEBS letters, 1988-01, Vol.240 (1-2), p.167-170

1988

Volltextzugriff (PDF)

The effect of dietary polyunsaturated fatty acids (PUFA) on acute rejection and cardiac allograft blood flow in rats

Transplantation, 1995-09, Vol.60 (6), p.570-576

1995

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(44)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Humans
(14)
Male
(12)
Female
(9)
Middle Aged
(8)
Adult
(7)
Cross-Over Studies
(7)
Ecology
(7)
Exenatide
(7)
Animals
(6)
Endocrinology & Metabolism
(6)
Hypoglycemic Agents - Pharmacology
(6)
Pharmacokinetics
(6)
Pharmacology & Pharmacy
(6)
Aged
(5)
Biological And Medical Sciences
(5)
Diabetes Mellitus, Type 2 - Drug Therapy
(5)
Environmental Sciences
(5)
Peptides - Adverse Effects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action

Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes

PO428 COMPARATIVE PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF LY2963016 INSULIN GLARGINE AND EU- AND US-APPROVED VERSIONS OF LANTUS® INSULIN GLARGINE IN HEALTHY SUBJECTS

PO427 COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 INSULIN GLARGINE PRODUCTS, LY2963016 AND LANTUS® IN HEALTHY SUBJECTS AT 2 DOSE LEVELS

Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetes

Exenatide effects on statin pharmacokinetics and lipid response

The effect of exenatide on lisinopril pharmacodynamics and pharmacokinetics in patients with hypertension

Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes

A thorough QT study to evaluate the effects of singledose exenatide 10 μg on cardiac repolarization in healthy subjects

Exenatide pharmacokinetics in healthy Chinese subjects

Effect of exenatide on lisinopril pharmacodynamics in patients treated for hypertension

Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium

Effect of Exenatide on the Steady-State Pharmacokinetics of Digoxin

A single-dose pharmacokinetic study of basal insulin peglispro (BIL) in subjects with hepatic impairment

The inflammatory and tumor-promoting sesquiterpene lactone, thapsigargin, activates platelets by selective mobilization of calcium as shown by protein phosphorylations

PIII-61Exenatide does not affect the pharmacokinetics and pharmacodynamics of warfarin in healthy male subjects

OIV-A-4Chinese are more sensitive to warfarin than Asian Indians despite similar pharmacokinetics and vitamin K levels

PII-39

PII-39Effects of exenatide on statin single-dose pharmacokinetics and 30-week lipid response

OIV-A-4

PIII-61

Einfluss von Exenatide auf die Pharmakokinetik einer Statin-Einzeldosis und die Lipidwerte nach 30 Wochen

Effect of amiloride on arachidonic acid and histamine release from rat mast cells

Inhibition by amiloride and by Na super(+)-depletion of A23187-stimulated arachidonic acid and histamine release from rat mast cells

The effect of dietary polyunsaturated fatty acids (PUFA) on acute rejection and cardiac allograft blood flow in rats

Suchergebnisse filtern